Covid-19 Antibody treatment from Clodomiro Picado Research Institute

The Costa Rican Clodomiro Picado Research Institute  announced this week that they have created two initial lots of Covid-19 antibody treatment to be utilized on the most critically ill patients.  According to the institute, the treatment involves the extraction of  equine immunoglobulins  in the plasma process and resulted in the first batch of 1,000 vials.

Costa Rican scientists will begin the quality control phase of the treatment to make certain that the serum is safe for patients before sending it to CCSS (Social Security). They also sent samples to George Mason University, in the United States to test its effectiveness.

In the next phase of the testing process, the treatment will be sent to the CCSS where the clinical results will be studied.

(Source AM Costa Rica and La Nacion)